PROBIO is a pet digestive care supplement in orally disintegrating tablet (ODT) form — a 2.5 g strip built on an oral fast-dissolving matrix and probiotic digestive nutrients, supplied 10 strips per pack. Its relevance to veterinary practice lies not only in what it contains but in how it is given: the strip dissolves on contact with saliva, requires no pilling, crushing, or dosing tools, and delivers a fixed unit dose every time a patient takes one.

This guide is written for veterinarians, veterinary nurses, and practice owners who want to place a fast-dissolving digestive supplement inside a working digestive care protocol — through post-antibiotic recovery windows, in the long-term management of sensitive patients, and in the many cases where a patient simply will not accept a tablet or a powdered supplement. It covers case selection, administration technique, monitoring, format comparison, and the supply questions a practice or distributor should answer before standardising on a product.

One boundary applies throughout. PROBIO is a nutritional supplement, not a therapeutic drug: it supports a protocol, and it does not replace diagnosis, dietary management, or prescribed treatment.

Problem Definition: Where Digestive Nutrition Breaks Down

Digestive support is an unusual category in veterinary practice because the protocol often succeeds or fails in the owner's hands rather than in the clinic. Novohope's product documentation identifies three recurring failure points in conventional supplement formats, and each one carries a clinical consequence:

• Feeding difficulty. Pets may refuse the product, hide it, or spit it out. Each failed attempt adds stress for the patient and frustration for the owner.
• Low, unstable absorption. Products that are swallowed and processed in the gastrointestinal tract are strongly affected by the patient's digestive condition, so the dose administered and the dose absorbed can diverge.
• Inaccurate dosing. When a powder is mixed into food, the amount actually consumed cannot be verified — a particular problem in multi-pet households or wherever a bowl is shared.

The practical consequence is familiar to most clinics: a supplement that is appropriate on paper is abandoned after a week because the owner cannot reliably get it into the patient. Chronic digestive support is usually a multi-week commitment, and adherence across that window decides whether the protocol was worth starting at all.

Two limits should be stated plainly. First, delivery format solves administration, not diagnosis: patients with weight loss, persistent vomiting, blood in the stool, or systemic signs still need a full work-up before any nutritional product is layered on top. Second, because PROBIO is a supplement, its role is supportive — alongside dietary management and whatever treatment the clinician prescribes.

Industry Background: Why Fast-Dissolving Formats Are Entering Veterinary Practice

Client demand for pet supplements has grown steadily, and veterinary teams are increasingly asked to comment on products that owners have already discovered online. Two research houses frame the size of that demand differently, which is itself useful context:

• Grand View Research values the global pet supplements market at approximately USD 2.8 billion in 2025, with projected growth to USD 4.6 billion by 2033.
• Mordor Intelligence estimates that the pet dietary supplements segment will reach USD 5.11 billion by 2026, growing at a CAGR of 7.42% through 2031.
• North America accounted for 48.1% of global pet supplement revenue share in 2025 (Grand View Research), while Asia-Pacific is projected as the fastest-growing region, driven by rising pet humanisation and healthcare expenditure in China and India (Mordor Intelligence).

The two 2025 figures do not match — Grand View Research reports USD 2.8 billion against Mordor Intelligence's USD 4.76 billion — because classification and scope differ between agencies. The direction of travel is consistent even where the absolute numbers are not, and that is the practical takeaway for a practice deciding whether digestive nutrition deserves dedicated protocol space.

Format innovation is moving in parallel. Oral dissolvable film technology in the pet sector is being developed around disintegration times below 25 seconds and taste-masking palatability improvements of up to 47% (Market Reports World). The Novohope oral strip line works from the same delivery principle: the strip dissolves quickly on contact with saliva instead of being swallowed whole.

On the compliance side, US buyers frequently encounter the NASC Quality Seal, issued by the National Animal Supplement Council, which requires adherence to Good Manufacturing Practices and rigorous labelling audits. It is one of several standards a practice or distributor may use when screening suppliers — and it is worth confirming exactly which registrations and certificates a specific manufacturer holds rather than assuming them.

What PROBIO Is: Format, Composition, and Delivery Logic

PROBIO is classified as a pet digestive care supplement in ODT form, made with an oral fast-dissolving matrix and probiotic digestive nutrients. Its stated position within the Novohope range is intestinal care and probiotic support: supporting healthy digestion and nutrient absorption while also improving overall coat condition. The specification is deliberately simple, because the format is the feature:

How the delivery actually works

• Dissolution. On contact with the patient's saliva, the strip dissolves rapidly — within about 10 seconds according to Novohope's product documentation. No water, crushing, or hiding in food is required.
• Absorption route. Active ingredients are absorbed through the oral mucosa and enter the bloodstream, bypassing gastrointestinal degradation. This route suits the physiology of pets, whose short intestines and high gastric acid levels can reduce the efficiency of swallowed formats.
• Stated efficiency. Novohope states an absorption rate of up to 95% for the mucosal route, compared with roughly 35% for traditional formats. These are manufacturer-stated figures rather than an independent clinical measurement, and they should be presented to clients as such.
• Unit-dose control. Each strip carries a precisely controlled quantity of nutrients, so every administration delivers a consistent dose and the guesswork of scooping powder into a bowl disappears.
• No tools, no handling stress. The pet can take the strip by licking it directly. The process requires no feeding action, no pill popper, and no restraint.

Ingredients and manufacturing context

Within the Novohope oral film line, probiotic content includes Bacillus coagulans (GBI-30, 6086) supplied at 1×10⁹ CFU per film, alongside postbiotics and GOS & XOS prebiotic fibres used across the range. PROBIO is one of seven Novohope series — COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO, and Fit+ — each built on the same fast-dissolving matrix with a different nutrient base for a different health scenario.

The manufacturer behind the brand is Wuxi Novohope Biotechnology Co., Ltd., established in 2025, operating a 20,000 m² manufacturing facility with a workforce of approximately 25 employees, an annual production capacity of 200,000,000 boxes, and an R&D team of 12 engineers. Approximately 95% of products are exported, serving markets in Europe, America, Britain, the Middle East, Japan, and South Korea. For a practice or distributor assessing supply continuity, those capacity and export figures are the relevant first-party data points.

Step-by-Step: Integrating PROBIO Into a Digestive Care Protocol

Introducing an ODT supplement into clinical practice is a seven-step process. The sequence below is written so that a clinic can adapt it to its own standard operating procedures rather than adopt a template wholesale.

Step 1 — Screen the case for suitability

The clearest candidates are patients in a post-antibiotic recovery window, patients with chronic intermittent digestive sensitivity already under veterinary supervision, and patients with a documented history of refusing tablets or powders. Novohope's product documentation notes that specific pet issues should be matched to the corresponding product series and model, and that no special requirements apply during usage. Patients with undiagnosed systemic signs should complete a diagnostic work-up before a nutritional product is added to the plan.

Step 2 — Record a baseline before starting

Document body weight, current diet, appetite, stool consistency, coat condition, and concurrent medications or supplements. Note the owner's previous experience with delivery formats, since a household that has already failed with powders will need a different coaching conversation. A baseline is what allows the review appointment to be a judgement rather than a guess.

Step 3 — Confirm the format fits the patient

ODT delivery is most valuable where administration is the limiting factor: cats, small-breed dogs, patients on multi-week regimens, and animals that become stressed by handling. The same strip principle carries across the Novohope series, so a practice managing several digestive and non-digestive cases can keep one administration routine for the owner to learn.

Step 4 — Train the owner on administration

Instructions are short by design: store the pack at room temperature, keep strips in the original packaging, use dry hands, and offer the strip directly for the pet to lick. Nothing needs to be pre-soaked, crushed, or mixed. One strip is one dose, and PROBIO packs contain 10 strips. The frequency and duration of administration remain a clinical decision for the veterinarian, guided by the product's labelled directions and the individual case — the fixed unit dose simply removes measurement error from the owner's side.

Step 5 — Set a monitoring window

Give the owner a simple log covering each administration, appetite, stool observations, and any difficulty encountered. Compliance data collected at home is more useful at review than a verbal summary, particularly when the protocol runs for several weeks.

Step 6 — Review and decide on continuation

At review, compare against the baseline and the owner's log. If the format is being accepted consistently, continuation becomes a clinical decision about the patient's nutritional support plan. If administration is still failing, the format is not the problem and the conversation should move to technique, timing, or a different support approach.

Step 7 — Standardise the protocol in the practice

Once a practice has validated the format on a handful of cases, it can be written into the internal protocol: which cases trigger a recommendation, what owner instructions are handed out, how stock is managed at 10 strips per pack, and how the product is recorded in the patient's history. Standardisation is what turns an individual success into a repeatable service.

Clinical Use Cases Where the ODT Format Matters Most

Post-antibiotic recovery windows

Antibiotic courses are often followed by a period in which the owner wants to support digestive comfort. PROBIO is positioned as nutritional support with probiotic digestive nutrients for exactly that window, used as an adjunct alongside whatever treatment the clinician has prescribed. Its role is supportive, and it does not alter the antibiotic protocol itself.

Chronic intermittent digestive sensitivity

Long-running cases are adherence cases. A strip that dissolves in about 10 seconds and delivers a fixed dose is easier to sustain over weeks than a powder that must be measured into a bowl twice a day, and it avoids the daily negotiation that erodes owner commitment.

Finicky cats and small-breed dogs

Patients that will not accept tablets are the strongest candidates for a fast-dissolving format. Because the strip is taken by licking and no tools are required, the administration event is brief and the pet cannot easily hide or spit out the dose in the way it can with a tablet.

Multi-pet households and shared feeding

Where several animals eat together, a measured powder cannot be attributed reliably to one patient. A single strip given directly to the intended animal resolves the ambiguity, which matters when the clinician needs to evaluate whether the patient actually received the protocol.

Discharge and referral handoffs

Patients going home with several items to administer place a load on the owner. Adding a supplement that requires no preparation and no equipment reduces the number of tasks in the discharge plan, which is particularly relevant in specialty and referral settings where instructions are already complex.

Format Comparison: PROBIO ODT Against Conventional Digestive Supplement Formats

The table below summarises how the fast-dissolving format differs from conventional powders, tablets, and chewables. It reflects Novohope's own product documentation, in which the three challenges of traditional formats are set against the ODT solution; the absorption figures are manufacturer-stated rather than independently verified.

This is a format comparison, not an efficacy claim. Absorption percentages are vendor-stated, and clinical outcomes depend on the individual patient, the diagnosis, the diet, and the rest of the protocol. A supplement should not be positioned as a replacement for diagnostic or therapeutic intervention.

FAQ: Compliance, Capability, Cost, Samples, and Supply

Is PROBIO a veterinary medicine or a nutritional supplement, and what documentation should a clinic check?

PROBIO is classified as a pet digestive care supplement in ODT form, not a pharmaceutical product, so it cannot substitute for prescribed treatment. Within the Novohope line, the stated credentials are FDA food registration in the United States, a GS1 international product code, and SDS and COA test reports. Separately, the NASC Quality Seal is a widely referenced US standard for animal supplements that requires adherence to Good Manufacturing Practices and rigorous labelling audits — it is not automatically held by every supplier. The practical rule is to confirm which specific registrations and certificates a manufacturer actually holds rather than assuming them from category-level marketing.

How does the fast-dissolving format improve compliance in sensitive pets?

The strip is designed to dissolve within about 10 seconds of contact with saliva, so it is taken by the pet licking it directly — no pill popper, no crushing, no mixing into food, and no restraint. Because each strip carries a precisely controlled quantity of nutrients, every administration is a fixed unit dose, which removes the measurement error typical of powders. The route also differs: ingredients are absorbed through the oral mucosa and bypass the gastrointestinal tract, which Novohope states results in an absorption rate of up to 95% against roughly 35% for traditional formats. Each PROBIO strip weighs 2.5 g and packs contain 10 strips.

What drives the cost of adding PROBIO to a practice or retail programme?

Cost is specification-driven rather than a single list price: strip weight and unit dose, pack configuration (PROBIO is supplied at 2.5 g per strip, 10 strips per pack), the nutrient base, labelling and packaging requirements for the destination market, and whether the buyer requires private-label or OEM customisation. Novohope publishes no fixed retail pricing in its product documentation, so quotations are prepared against a defined specification and order volume. When assessing volume supply, the relevant first-party figure is the stated annual production capacity of 200,000,000 boxes from a 20,000 m² facility.

Can a clinic or distributor evaluate PROBIO before standardising protocols?

Yes. Practices and distributors can request product information, samples, and a quotation from Novohope before committing to a protocol or a retail listing. Evaluating the format on a small number of real cases — particularly patients with a history of refusing tablets or powders — gives a clinical team direct evidence of how the strip behaves in its own client population. Novohope's product information is published at novohope.com.

What supply factors should be checked before listing PROBIO?

Three verifiable points matter: manufacturing base, capacity, and export coverage. Wuxi Novohope Biotechnology Co., Ltd. was established in 2025 and operates a 20,000 m² facility with approximately 25 employees and an R&D team of 12 engineers, reporting an annual production capacity of 200,000,000 boxes. Approximately 95% of products are exported, serving markets in Europe, America, Britain, the Middle East, Japan, and South Korea. Specific lead times, minimum order quantities, and delivery terms are confirmed at quotation stage, so they should be requested together with the specification. Clinics and distributors ready to move forward can request a sample and a quote directly from Novohope.

Conclusion: Where PROBIO Fits in a Digestive Care Protocol

PROBIO earns its place in a veterinary digestive care protocol for a specific reason: it removes the administration barrier that ends most at-home supplement programmes. A 2.5 g strip with an oral fast-dissolving matrix and probiotic digestive nutrients, supplied 10 strips per pack, dissolves on saliva contact, requires no tools, and delivers a controlled unit dose every time. For post-antibiotic recovery windows, chronic sensitive patients, finicky cats, and multi-pet households, that combination of format and consistency is what keeps a protocol running for the weeks it needs.

The limitations are equally clear and should be respected. It is a nutritional supplement, not a treatment; absorption figures are vendor-stated; and diagnosis remains a clinical process. Used inside those boundaries, a fast-dissolving strip is a practical, low-friction addition to the way digestive support is delivered in practice.

Next Step: Evaluate PROBIO in Your Own Practice

Novohope supplies pet oral dissolving film products — including PROBIO, COAT+, EYES+, CALM+, BONE+, HEART+, and Fit+ — to clinics, distributors, and brand partners, with approximately 95% of products exported to markets in Europe, America, Britain, the Middle East, Japan, and South Korea. Clinics and distributors can request a sample, a quotation, or product documentation to test the format on real cases before standardising a protocol.

Request a PROBIO sample, specification sheet, or quote from Novohope